Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
34.70
-1.08 (-3.02%)
Aug 11, 2026, 10:53 AM EDT - Market open
Roivant Sciences Revenue
Roivant Sciences had revenue of $1.44M in the quarter ending June 30, 2026, a decrease of -33.55%. This brings the company's revenue in the last twelve months to $7.53M, down -67.58% year-over-year. In the fiscal year ending March 31, 2026, Roivant Sciences had annual revenue of $8.26M, down -71.57%.
Revenue (ttm)
$7.53M
Revenue Growth
-67.58%
P/S Ratio
3,431.32
Revenue / Employee
$10,447
Employees
721
Market Cap
25.06B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 8.26M | -20.79M | -71.57% |
| Mar 31, 2025 | 29.05M | -3.66M | -11.19% |
| Mar 31, 2024 | 32.71M | -28.57M | -46.62% |
| Mar 31, 2023 | 61.28M | 5.99M | 10.84% |
| Mar 31, 2022 | 55.29M | 31.49M | 132.34% |
| Mar 31, 2021 | 23.80M | -43.89M | -64.85% |
| Mar 31, 2020 | 67.69M | 65.37M | 2,812.61% |
| Mar 31, 2019 | 2.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 6.13B |
| Incyte | 5.82B |
| Alnylam Pharmaceuticals | 4.80B |
| Jazz Pharmaceuticals | 4.60B |
| Genmab | 4.13B |
| BioNTech SE | 3.03B |
| Royalty Pharma | 2.54B |
| Moderna | 2.23B |
ROIV News
- 1 day ago - Roivant Sciences price target raised to $37 from $35 at BofA - TheFly
- 1 day ago - Roivant Sciences price target raised to $46 from $42 at Citi - TheFly
- 4 days ago - Roivant Sciences price target raised to $42 from $36 at Guggenheim - TheFly
- 4 days ago - Roivant Sciences price target raised to $41 from $34 at H.C. Wainwright - TheFly
- 4 days ago - TD Cowen boosts Roivant Sciences price target, says has many catalysts on deck - TheFly
- 5 days ago - Roivant Sciences Earnings Call Transcript: Q1 2027 - Transcripts
- 5 days ago - Roivant Sciences Quarterly report: Q1 2027 - Filings
- 5 days ago - Roivant Sciences Slides: Q1 2027 - Filings